Written question asked by Lord Hylton (Crossbench), in the House of Lords. It was due for an answer on Monday, 11 October 1999. It was answered by Baroness Hayman (Labour) on Monday, 11 October 1999.

---

Hayman, Baroness

Question

In relation to the genetically engineered hormone rBST, which stimulates IGF-1, a blood hormone which causes cells to divide, whether women with relatively small increases in their blood-levels of IGF-1 are up to seven times more likely to develop post-menopausal breast cancer. [HL 4005].

---

Secondary information

Type

Written question

Reference

605 c47WA; HL 4005

Session

1998-99

Subjects

Breast cancer Health hazards Hormone treatments Bovine somatotropin